Hydrogels comprising cell adhesive peptides and methods of use thereof
US-2024376438-A1 · Nov 14, 2024 · US
US9447381B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9447381-B2 |
| Application number | US-201414553442-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 25, 2014 |
| Priority date | Nov 10, 2009 |
| Publication date | Sep 20, 2016 |
| Grant date | Sep 20, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A medium for growing vascular lineage cells is described. The vascular lineage cell growth medium includes an oligosaccharide-based hydrogel and a growth factor that promotes vascularization by vascular lineage cells.
Opening claim text (preview).
We claim: 1. A method of preparing a vascular lineage cell growth medium comprising chemically bonding an adhesion promoter to an oligosaccharide, combining the chemically bonded adhesion promoter and oligosaccharide with at least one growth factor, adding a crosslinking peptide moiety, curing the combination to form a hydrogel, wherein the hydrogel has a Young's modulus between about 10 Pa and about 500 Pa; and wherein the growth factor is an amount sufficient to promote vasculogenesis and tube formation, and sufficient to stimulate MMP production in vascular lineage cells. 2. The method of claim 1 , wherein the oligosaccharide is hyaluronic acid that is from about 20% to about 90% acrylate modified and is present in an amount of about 1 wt % to about 4 wt %. 3. The method of claim 1 , wherein the adhesion promoter is present at a concentration of from about 0.1 mM to about 20 mM. 4. The method of claim 1 , wherein the crosslinking peptide moiety is present at a concentration of from about 1 mM to about 8 mM. 5. The method of claim 1 , wherein the growth factor is present at a concentration of from about 25 ng/ml to about 200 ng/ml. 6. The method of claim 1 , wherein the hydrogel allows formation of capillary-like structures (CLSs) with extended vacuoles and open lumens from vascular lineage cells. 7. The method of claim 1 , wherein the hydrogel and crosslinking peptide moiety are cleavable by an enzyme. 8. The method of claim 7 , wherein the enzyme is a matrix metalloproteinase. 9. The method of claim 8 , wherein the matrix metalloproteinase is at least one of MMP-1, MMP-2 or MMP-10. 10. The method of claim 1 , wherein the crosslinking moiety peptide comprises the sequence SEQ ID NO: 1. 11. The method of claim 1 , wherein the adhesion promoter promotes vascular lineage cell adhesion to the hydrogel and promotes vacuole and lumen formation in vascular lineage cells. 12. The method of claim 1 , wherein the hydrogel has a Young's modulus between about 10 Pa and about 250 Pa. 13. The method of claim 1 , wherein the oligosaccharide is modified with an acryl group. 14. The method of claim 1 , wherein the oligosaccharide is acrylated hyaluronic acid. 15. The method of claim 1 , wherein the growth factor is selected from the group consisting of VEGF, TNFα, SDF1-α, bFGF, angiopoetin-1, PDGF, TGF-β, PIGF or combinations thereof. 16. The method of claim 1 , wherein the adhesion promoter is a peptide that includes an RGD sequence and a reactive functional group that is capable of bonding the adhesion promoter to the oligosaccharide. 17. A vascular lineage cell growth medium prepared by the method of claim 16 , wherein the oligosaccharide is acrylated hyaluronic acid. 18. A method of inducing vascular cell morphogenesis in vivo comprising contacting a subject with a vascular construct comprising the medium of claim 17 and vascular lineage cells. 19. The method of claim 18 , wherein the crosslinking moiety peptide comprises the sequence SEQ ID NO: 1. 20. The method of claim 18 , wherein the growth factor is selected from the group consisting of VEGF, TNFα, SDF1-α, bFGF, angiopoetin-1, PDGF, TGF-β, PIGF or combinations thereof. 21. The method of claim 1 , wherein the oligosaccharide is modified with a thiol group.
Transforming growth factor alpha [TGF-a] · CPC title
Vascular endothelial growth factor [VEGF] · CPC title
Proteins · CPC title
Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells · CPC title
Growth factors · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.